CN Patent

CN111163756B — 氯普鲁卡因的局部制剂

Assigned to Sintetica SA · Expires 2022-04-15 · 4y expired

What this patent protects

提供了氯普鲁卡因的局部剂型和制剂，包括凝胶剂和软膏剂，及其制备和应用的方法，其对于安全和功效是有效的、化学稳定的并且是生理学上平衡的。基于其耐受性和药物动力学，该剂型和制剂特别可用于眼科操作期间或对眼擦伤和创伤的响应中。

USPTO Abstract

提供了氯普鲁卡因的局部剂型和制剂，包括凝胶剂和软膏剂，及其制备和应用的方法，其对于安全和功效是有效的、化学稳定的并且是生理学上平衡的。基于其耐受性和药物动力学，该剂型和制剂特别可用于眼科操作期间或对眼擦伤和创伤的响应中。

Drugs covered by this patent

chloroprocaine-hydrochloride (CHLOROPROCAINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN111163756B
Jurisdiction: CN
Classification: —
Expires: 2022-04-15
Drug substance claim: No
Drug product claim: No
Assignee: Sintetica SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.